These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9291206

  • 21. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC, Eismann U, Deppisch RM, Stein G.
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [Abstract] [Full Text] [Related]

  • 22. Dialysis-related amyloidosis of the external auditory canals.
    Ashimori N, Hayashi Y, Mineta H, Hoshino T.
    Am J Otolaryngol; 2002 Feb; 23(6):374-7. PubMed ID: 12430131
    [Abstract] [Full Text] [Related]

  • 23. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D, Gallieni M, Niwa T, Braidotti P, Coggi G.
    J Nephrol; 2000 Feb; 13(2):129-36. PubMed ID: 10858976
    [Abstract] [Full Text] [Related]

  • 24. Amyloid deposition in the tongue: clinical and histopathological profile.
    Angiero F, Seramondi R, Magistro S, Crippa R, Benedicenti S, Rizzardi C, Cattoretti G.
    Anticancer Res; 2010 Jul; 30(7):3009-14. PubMed ID: 20683047
    [Abstract] [Full Text] [Related]

  • 25. Fatal cardiac beta2-microglobulin amyloidosis in patients on long-term hemodialysis.
    Kawano M, Muramoto H, Yamada M, Minamoto M, Araki H, Koni I, Mabuchi H, Nonomura A.
    Am J Kidney Dis; 1998 Mar; 31(3):E4. PubMed ID: 10074578
    [Abstract] [Full Text] [Related]

  • 26. Severe gastrointestinal complications of dialysis-related amyloidosis in two patients on long-term hemodialysis.
    Araki H, Muramoto H, Oda K, Koni I, Mabuchi H, Mizukami Y, Nonomura A.
    Am J Nephrol; 1996 Mar; 16(2):149-53. PubMed ID: 8919232
    [Abstract] [Full Text] [Related]

  • 27. Nodular macroglossia with combined light chain and beta-2 microglobulin deposition in a long-term dialysis patient.
    Bandini S, Bergesio F, Conti P, Mancini G, Cerretini C, Cirami C, Rosati A, Caselli GM, Arbustini E, Merlini G, Ficarra G, Salvadori M.
    J Nephrol; 2001 Mar; 14(2):128-31. PubMed ID: 11411015
    [Abstract] [Full Text] [Related]

  • 28. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature.
    Gal R, Korzets A, Schwartz A, Rath-Wolfson L, Gafter U.
    Arch Pathol Lab Med; 1994 Jul; 118(7):718-21. PubMed ID: 8024407
    [Abstract] [Full Text] [Related]

  • 29. Extended-Hours Hemodialysis without Dietary Restrictions Is Associated with Lower Risk for Developing of Dialysis-Related Amyloidosis.
    Tabata S, Kaneda F, Ohwada K, Nishiyama T, Kaneda H.
    Tohoku J Exp Med; 2021 Apr; 253(4):241-248. PubMed ID: 33828023
    [Abstract] [Full Text] [Related]

  • 30. The relationship between pentosidine and hemodialysis-related connective tissue disorders.
    Sakata S, Takahashi M, Kushida K, Oikawa M, Hoshino H, Denda M, Inoue T.
    Nephron; 1998 Apr; 78(3):260-5. PubMed ID: 9546683
    [Abstract] [Full Text] [Related]

  • 31. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R, Merta M, Tesar V, Lachmanová J, Sulková S, Bláha J.
    Cas Lek Cesk; 2002 Apr 26; 141(8):244-7. PubMed ID: 12038073
    [Abstract] [Full Text] [Related]

  • 32. Macromolecular crowding and supersaturation protect hemodialysis patients from the onset of dialysis-related amyloidosis.
    Nakajima K, Yamaguchi K, Noji M, Aguirre C, Ikenaka K, Mochizuki H, Zhou L, Ogi H, Ito T, Narita I, Gejyo F, Naiki H, Yamamoto S, Goto Y.
    Nat Commun; 2022 Oct 03; 13(1):5689. PubMed ID: 36192385
    [Abstract] [Full Text] [Related]

  • 33. Recent progress in understanding dialysis-related amyloidosis.
    Yamamoto S, Kazama JJ, Narita I, Naiki H, Gejyo F.
    Bone; 2009 Jul 03; 45 Suppl 1():S39-42. PubMed ID: 19303954
    [Abstract] [Full Text] [Related]

  • 34. Cystic beta2-microglobulin amyloidoma in a patient on long-term hemodialysis.
    Ogata H, Koiwa F, Takahashi J, Takahashi K, Shiokawa A, Kitanosono T, Kinugasa E, Taguchi S.
    Clin Exp Nephrol; 2006 Jun 03; 10(2):159-61. PubMed ID: 16791406
    [Abstract] [Full Text] [Related]

  • 35. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G.
    Blood Purif; 2007 Jun 03; 25(5-6):432-40. PubMed ID: 17957097
    [Abstract] [Full Text] [Related]

  • 36. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S, Gejyo F.
    Biochim Biophys Acta; 2005 Nov 10; 1753(1):4-10. PubMed ID: 16226497
    [Abstract] [Full Text] [Related]

  • 37. Hemodialysis-associated soft tissue amyloidomas of the chest and abdominal wall.
    Nasir J, Der Mesropian PJ, Foulke L, Salman L, Haqqie S, Shaikh G.
    Hemodial Int; 2020 Jan 10; 24(1):E1-E4. PubMed ID: 31680424
    [Abstract] [Full Text] [Related]

  • 38. Dialysis-related amyloidosis: importance of biocompatibility and age.
    Jadoul M.
    Nephrol Dial Transplant; 1998 Jan 10; 13 Suppl 7():61-4. PubMed ID: 9870440
    [Abstract] [Full Text] [Related]

  • 39. [Mixed type amyloidomas, beta2 microglobulin and AL lambda, in a long term hemodialysis patient].
    Menet E, Petit ML, Bridoux F, Touchard G, Duport G, Levillain P, Babin P.
    Nephrologie; 2001 Jan 10; 22(3):115-8. PubMed ID: 11436666
    [Abstract] [Full Text] [Related]

  • 40. Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?
    Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch KM, Floege J.
    Kidney Int; 1997 Oct 10; 52(4):1077-83. PubMed ID: 9328948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.